Developer docs
API playgroundTry for free, no card

Search company profiles

HIN Sang Group

Full company profile

uuid003mori

Namestring
HIN Sang Group
Legal namestring
Hin Sang Group (International) Holding Co. Ltd.
Company typeenum
Public
Founded yearint
1996
Descriptiontext

HIN Sang Group (International) Holding Co. Ltd. (HKEX:6893) is a Cayman Islands-incorporated holding company founded in 1996 by Pang Siu Hin and Kwan Lai Man, listed on the Hong Kong Stock Exchange in September 2014. The group operates a vertically integrated branded health products business focused on children's healthcare, Chinese medicines, nutritional supplements, adult health products, and skincare, organized around two core brands — Hin Sang (launched 2004, 15 consecutive years as No.1 Brand for Children's Vitamins and Dietary Supplements in Hong Kong) and Beautymate (skincare, launched 2009). Its flagship proprietary Chinese medicine, Febrifuge (Granules), is the only young child-specific proprietary Chinese medicine in granule form registered with the Hong Kong Department of Health.

The group's manufacturing is anchored by the Hin Sang Health Medical Industrial Park in Yunfu City, Guangdong Province, which obtained Food and Food Additive Production License SC Certification and operates multiple fully automatic production and packaging lines under GMP standards, serving both own-brand production and OEM/ODM contract manufacturing for beverages, convenience foods, and confectionery. Revenue is generated through (a) own-brand product sales across retail chains (Manning's, Watson's, CRCare), pharmacies, e-commerce platforms (including Suning in mainland China), and proprietary Pengzu Hin Sang Pavilion chain stores in the PRC established via a 2021 joint venture with Hongli Homologous Biotechnology; and (b) OEM/ODM manufacturing services. Geographic distribution spans Mainland China, Hong Kong, Macau, Taiwan, and Southeast Asia. FY2025/26 revenue was HK$104.6 million (+13.8% YoY) with a 60.9% gross margin but a net loss of HK$45.5 million, and the company is pursuing property disposals (HK$183M aggregate indicative value) to deleverage while navigating an April 2026 leadership transition triggered by the founder/CEO's criminal custody in the PRC.

Short descriptiontext

HIN Sang Group (HKEX:6893) develops, manufactures, and distributes children's healthcare products, Chinese medicines, nutritional supplements, and skincare under its Hin Sang and Beautymate brands, plus OEM/ODM services, across Greater China and Southeast Asia.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersKowloon City, Hong Kong SAR China
HQ citystring
Kowloon City
HQ countrystring
Hong Kong SAR China
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
children's health supplements, Chinese medicine products, personal care products, nutritional supplements, OEM manufacturing services
Industry2 codes
PRIMARYCRADAGAJ
Children’s Vitamins & Supplements
SECONDARYCRADAMAD
Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
NAICS code1 code
  • Health and Personal Care Retailers456
SIC code2 codes
  • Perfumes, Cosmetics & Other Toilet Preparations2844
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Children's Healthcare and Nutritional Supplements
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Own Brand Product Sales
TypeOne Time License
Description

The company generates revenue primarily through the sale of its own brand health supplements, infant vitamins, nutritional supplements, adult health products, Chinese medicines, personal care, and skincare products. Revenue for FY2025/26 was HK$104.6 million with gross profit of HK$63.8 million.

hinsanggroup.com
2OEM/ODM Manufacturing Services
TypeProfessional Services
Description

The company provides Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) manufacturing services, producing beverages, convenience foods, and confectionery products that meet GMP requirements for external brands and clients.

hinsanggroup.com
3Property Disposal
TypeOne Time License
Description

The company is in the process of potentially disposing of properties (Shatin property with carpark at indicative asking price of HK$138 million and Tsim Sha Tsui property at HK$45 million) to realize cash and reduce bank borrowings.

hinsanggroup.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales
Pricing details2 tiers
1Hin Sang Febrifuge (Granules) - proprietary Chinese medicine for young children
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Suggested retail price HK$68.9 per package, available at Manning's, Watson's, CRCare and pharmacies in Hong Kong. Registered as proprietary Chinese medicine by Department of Health.

hinsanggroup.com
2Beautymate Acne Repairing Serum - skincare product
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Suggested selling price HK$59.9 per unit, available at Manning's, Watson's and pharmacies across Hong Kong.

hinsanggroup.com
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Beautymate
Description

Skincare brand launched in 2009, known for products such as Acne Repairing Serum

hinsanggroup.com
+1 more record
Core offering1 text field

Hin Sang Group manufactures and sells children's healthcare products (infant vitamins, nutritional supplements, and adult health products) under the flagship Hin Sang brand, personal care and skincare products under the Beautymate brand, and proprietary Chinese medicines (including the Febrifuge Granules). In addition, the group provides OEM and ODM manufacturing services for external brand owners producing beverages, convenience foods, and confectionery products that meet GMP requirements, operated from its Hin Sang Health Medical Industrial Park in Yunfu City, Guangdong Province.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • HK$104.6 million revenue in FY2025/26, up 13.8% year-over-year
+2 more records
Product overview1 text field

HIN Sang Group is a brand management and manufacturing company primarily engaged in children's healthcare, Chinese medicines, and traditional Chinese medical related projects. The company's core offering is the 'Hin Sang' flagship brand product series (infant vitamins, nutritional supplements, adult health products), which is supplemented by the 'Beautymate' skincare sub-brand. The group operates its own manufacturing through the Hin Sang Health Medical Industrial Park in Guangdong Province and provides OEM/ODM manufacturing services to third parties. Products are distributed across Mainland China, Hong Kong, Macau, Taiwan, and Southeast Asia. The company was founded in 1996 and has been certified as the No.1 Brand for Children's Vitamins and Dietary Supplements in Hong Kong for 15 consecutive years.

Product and service6 records
1Hin Sang Series
CategoryChildren's healthcare and nutritional supplements
Description

Flagship own-brand product line combining traditional herbal ingredients and advanced technology. Includes infant vitamins, nutritional supplements, and adult health products. Certified as No.1 Brand for Children's Vitamins and Dietary Supplements in Hong Kong for 15 consecutive years. Targeted at parents, caregivers, and adult consumers across Hong Kong, Mainland China, Macau, Taiwan, and Southeast Asia.

2Febrifuge (Granules)
CategoryProprietary Chinese medicine
Description

Proprietary Chinese medicine in granule form for young children to relieve fever, fight influenza virus, and boost immune systems. The only young child-specific proprietary Chinese medicine in granule form in Hong Kong, registered with and approved by the Department of Health. HKC certificate accredited. Suggested retail price HK$68.9 per package.

3Beautymate (skincare brand)
CategorySkincare and personal care
Description

Skincare brand launched in 2009, featuring products such as Acne Repairing Serum. Has become one of the company's best-selling brands in Asia. Distributed through Manning's and Watson's stores and pharmacies across Hong Kong.

4Beautymate Acne Repairing Serum
CategorySkincare and personal care
Description

Skincare product under the Beautymate brand designed to address acne concerns. Sold at Manning's and Watson's stores and pharmacies across Hong Kong at a suggested retail price of HK$59.9 per unit.

5OEM/ODM Manufacturing Services
CategoryContract manufacturing services
Description

Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services covering beverages, convenience foods, and confectionery products that meet GMP requirements. Produced at the Hin Sang Health Medical Industrial Park in Yunfu City, Guangdong Province, with SC Certification. Targeted at external brand owners and product companies needing contract manufacturing capacity.

6Aerospace Antivirus King and Bens Sterilizer (sole distributorship)
CategoryAntivirus and sterilization products
Description

Sterilization and antivirus products distributed under sole distributorship rights for Hong Kong and Macau markets.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1Hongli Homologous Biotechnology (Weihai) Company Limited (紅力同源生物科技(威海)有限公司)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-12-29
Description

On 29 December 2021, Hin Sang Health and Medical (Guangdong) Company Limited (衍生健康醫藥(廣東)有限公司), a wholly-owned subsidiary of the company, entered into a cooperation agreement with Hongli Homologous Biotechnology (Weihai) Company Limited to establish Pengzu Hin Sang Pavilion (Guangdong) Brand Management Company Limited (彭祖衍生館(廣東)品牌管理有限公司). The new brand management company opens chain stores in the name of 'Pengzu Hin Sang Pavilion' (彭祖衍生館) in the PRC, exclusively selling products supplied by Hin Sang Guangdong.

hinsanggroup.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2016-04-27
Description

On 27 April 2016, the company entered into a joint venture agreement with Fullshare Holdings Limited for the development of mother and child health products, pharmaceutical factory, hospital, medical centre and related services. The company subscribed for 306,000,000 JV Shares for HK$30,600,000 (51% of JV Company), while Fullshare subscribed for 294,000,000 JV Shares for HK$29,400,000 (49%). The company also provided a Shareholder's Loan of not less than HK$69,400,000 to the JV Company. Fullshare Holdings is a substantial shareholder of the company. Ms. Tian Shanshan, a non-executive director, serves as president assistant of Fullshare Holdings.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

China's largest nutritional supplement manufacturer offering vitamins and supplements including children's health products. Comparable in product category (vitamins, supplements) with broadly overlapping target demographics.

TypeDirect peer
Description

Hong Kong-headquartered traditional Chinese medicine company with branded TCM products and Chinese medicine granules. Comparable product portfolio (proprietary Chinese medicine granules) and HK distribution focus.

TypeEmerging player
Description

Premium Australian vitamins and supplements brand owned by H&H Group (Biostime), heavily distributed in China and Asia through cross-border and pharmacy channels. Comparable as a vitamins/supplements brand competing for the same Chinese consumer.

TypeEmerging player
Description

Asia-Pacific premium vitamins and supplements brand expanding into China and Southeast Asia. Comparable as a brand-led vitamins/supplements specialist with growing Asia presence; competes in the same end-markets as Hin Sang.

TypeRegional player
Description

Hong Kong-listed consumer products company specializing in personal care (tissue, sanitary, skin care) and sold through similar retail pharmacy channels in Greater China. Comparable in personal care product line and Mandarin-speaking market distribution.

TypeBroad incumbent
Description

Large-scale Chinese medicine manufacturer controlled by Sinopharm Group, covering the full TCM value chain from cultivation to retail. Comparable as a regulated Chinese medicine player with manufacturing and distribution; broader in scale than Hin Sang.

TypeDirect peer
Description

Hong Kong-based health supplement and Chinese medicine manufacturer with own brands focused on adult and child health products. Highly comparable as a HK-domiciled CPG health supplements brand using Chinese medicine heritage.

TypeBroad incumbent
Description

China-based direct-selling and consumer health products company owned by LKK Health Products Group, focused on Chinese herbal health supplements and personal care. Comparable in TCM-based health products and own-brand distribution model.

TypeDirect peer
Description

Hong Kong-based health and personal care retailer/distributor operating pharmacy chains and health product distribution. Closely comparable to Hin Sang's pharmacy-led distribution of healthcare products and Chinese medicines across Hong Kong.

TypeDirect peer
Description

Hong Kong-listed Chinese medicine company with retail chain distribution and proprietary Chinese medicine products. Comparable in product category (proprietary Chinese medicine) and pharmacy-led retail distribution model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

HIN Sang Group

Children's Healthcare and Nutritional Supplementshinsanggroup.com

HIN Sang Group (HKEX:6893) develops, manufactures, and distributes children's healthcare products, Chinese medicines, nutritional supplements, and skincare under its Hin Sang and Beautymate brands, plus OEM/ODM services, across Greater China and Southeast Asia.

What HIN Sang Group does

HIN Sang Group (International) Holding Co. Ltd. (HKEX:6893) is a Cayman Islands-incorporated holding company founded in 1996 by Pang Siu Hin and Kwan Lai Man, listed on the Hong Kong Stock Exchange in September 2014. The group operates a vertically integrated branded health products business focused on children's healthcare, Chinese medicines, nutritional supplements, adult health products, and skincare, organized around two core brands — Hin Sang (launched 2004, 15 consecutive years as No.1 Brand for Children's Vitamins and Dietary Supplements in Hong Kong) and Beautymate (skincare, launched 2009). Its flagship proprietary Chinese medicine, Febrifuge (Granules), is the only young child-specific proprietary Chinese medicine in granule form registered with the Hong Kong Department of Health.

The group's manufacturing is anchored by the Hin Sang Health Medical Industrial Park in Yunfu City, Guangdong Province, which obtained Food and Food Additive Production License SC Certification and operates multiple fully automatic production and packaging lines under GMP standards, serving both own-brand production and OEM/ODM contract manufacturing for beverages, convenience foods, and confectionery. Revenue is generated through (a) own-brand product sales across retail chains (Manning's, Watson's, CRCare), pharmacies, e-commerce platforms (including Suning in mainland China), and proprietary Pengzu Hin Sang Pavilion chain stores in the PRC established via a 2021 joint venture with Hongli Homologous Biotechnology; and (b) OEM/ODM manufacturing services. Geographic distribution spans Mainland China, Hong Kong, Macau, Taiwan, and Southeast Asia. FY2025/26 revenue was HK$104.6 million (+13.8% YoY) with a 60.9% gross margin but a net loss of HK$45.5 million, and the company is pursuing property disposals (HK$183M aggregate indicative value) to deleverage while navigating an April 2026 leadership transition triggered by the founder/CEO's criminal custody in the PRC.

HIN Sang Group firmographics

Firmographics
Name
HIN Sang Group
Legal name
Hin Sang Group (International) Holding Co. Ltd.
Website
https://hinsanggroup.com
Company type
Public
Founded year
1996
Operating status
Operating
Headcount range
101–250 employees
Short description
HIN Sang Group (HKEX:6893) develops, manufactures, and distributes children's healthcare products, Chinese medicines, nutritional supplements, and skincare under its Hin Sang and Beautymate brands, plus OEM/ODM services, across Greater China and Southeast Asia.
Ownership category
akta.pro rank

HIN Sang Group industry classification

Industry
Product category
Children's Healthcare and Nutritional Supplements
NAICS
Health and Personal Care Retailers (456)
SIC
Perfumes, Cosmetics & Other Toilet Preparations (2844), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYCRADAGAJ
Children’s Vitamins & Supplements
SECONDARYCRADAMAD
Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)

Keywords

  • Children's health supplements
  • Chinese medicine products
  • Personal care products
  • Nutritional supplements
  • OEM manufacturing services

Where HIN Sang Group is headquartered

Location

Headquarters

HQ city
Kowloon City
HQ country
Hong Kong SAR China
HQ region
Asia

Offices2 records

Markets served

HIN Sang Group business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

  1. Own Brand Product Sales: The company generates revenue primarily through the sale of its own brand health supplements, infant vitamins, nutritional supplements, adult health products, Chinese medicines, personal care, and skincare products. Revenue for FY2025/26 was HK$104.6 million with gross profit of HK$63.8 million.
  2. OEM/ODM Manufacturing Services: The company provides Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) manufacturing services, producing beverages, convenience foods, and confectionery products that meet GMP requirements for external brands and clients.
  3. Property Disposal: The company is in the process of potentially disposing of properties (Shatin property with carpark at indicative asking price of HK$138 million and Tsim Sha Tsui property at HK$45 million) to realize cash and reduce bank borrowings.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goHin Sang Febrifuge (Granules) - proprietary Chinese medicine for young children
Unit PricingPay-as-you-goBeautymate Acne Repairing Serum - skincare product

Go-to-market motion2 records

Distribution channels6 records

Marketing channels5 records

HIN Sang Group product offering

Product offering

Core offering

Hin Sang Group manufactures and sells children's healthcare products (infant vitamins, nutritional supplements, and adult health products) under the flagship Hin Sang brand, personal care and skincare products under the Beautymate brand, and proprietary Chinese medicines (including the Febrifuge Granules). In addition, the group provides OEM and ODM manufacturing services for external brand owners producing beverages, convenience foods, and confectionery products that meet GMP requirements, operated from its Hin Sang Health Medical Industrial Park in Yunfu City, Guangdong Province.

Product overview

HIN Sang Group is a brand management and manufacturing company primarily engaged in children's healthcare, Chinese medicines, and traditional Chinese medical related projects. The company's core offering is the 'Hin Sang' flagship brand product series (infant vitamins, nutritional supplements, adult health products), which is supplemented by the 'Beautymate' skincare sub-brand. The group operates its own manufacturing through the Hin Sang Health Medical Industrial Park in Guangdong Province and provides OEM/ODM manufacturing services to third parties. Products are distributed across Mainland China, Hong Kong, Macau, Taiwan, and Southeast Asia. The company was founded in 1996 and has been certified as the No.1 Brand for Children's Vitamins and Dietary Supplements in Hong Kong for 15 consecutive years.

Differentiator

Problem solved

Functional benefit

Brands

  • Beautymate: Skincare brand launched in 2009, known for products such as Acne Repairing Serum
  • Hin Sang

Products and services

  • Hin Sang Series Flagship own-brand product line combining traditional herbal ingredients and advanced technology. Includes infant vitamins, nutritional supplements, and adult health products. Certified as No.1 Brand for Children's Vitamins and Dietary Supplements in Hong Kong for 15 consecutive years. Targeted at parents, caregivers, and adult consumers across Hong Kong, Mainland China, Macau, Taiwan, and Southeast Asia.
  • Febrifuge (Granules) Proprietary Chinese medicine in granule form for young children to relieve fever, fight influenza virus, and boost immune systems. The only young child-specific proprietary Chinese medicine in granule form in Hong Kong, registered with and approved by the Department of Health. HKC certificate accredited. Suggested retail price HK$68.9 per package.
  • Beautymate (skincare brand) Skincare brand launched in 2009, featuring products such as Acne Repairing Serum. Has become one of the company's best-selling brands in Asia. Distributed through Manning's and Watson's stores and pharmacies across Hong Kong.
  • Beautymate Acne Repairing Serum Skincare product under the Beautymate brand designed to address acne concerns. Sold at Manning's and Watson's stores and pharmacies across Hong Kong at a suggested retail price of HK$59.9 per unit.
  • OEM/ODM Manufacturing Services Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services covering beverages, convenience foods, and confectionery products that meet GMP requirements. Produced at the Hin Sang Health Medical Industrial Park in Yunfu City, Guangdong Province, with SC Certification. Targeted at external brand owners and product companies needing contract manufacturing capacity.
  • Aerospace Antivirus King and Bens Sterilizer (sole distributorship) Sterilization and antivirus products distributed under sole distributorship rights for Hong Kong and Macau markets.

Quantifiable outcome

  • HK$104.6 million revenue in FY2025/26, up 13.8% year-over-year
  • +2 more outcomes

Companies that use HIN Sang Group

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles3 records

HIN Sang Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

HIN Sang Group partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Hongli Homologous Biotechnology (Weihai) Company Limited (紅力同源生物科技(威海)有限公司)coreStrategic or Co-development Partner · 29 December 2021On 29 December 2021, Hin Sang Health and Medical (Guangdong) Company Limited (衍生健康醫藥(廣東)有限公司), a wholly-owned subsidiary of the company, entered into a cooperation agreement with Hongli Homologous Biotechnology (Weihai) Company Limited to establish Pengzu Hin Sang Pavilion (Guangdong) Brand Management Company Limited (彭祖衍生館(廣東)品牌管理有限公司). The new brand management company opens chain stores in the name of 'Pengzu Hin Sang Pavilion' (彭祖衍生館) in the PRC, exclusively selling products supplied by Hin Sang Guangdong.
  • Fullshare Holdings Limited (Stock code: 607)coreStrategic or Co-development Partner · 27 April 2016On 27 April 2016, the company entered into a joint venture agreement with Fullshare Holdings Limited for the development of mother and child health products, pharmaceutical factory, hospital, medical centre and related services. The company subscribed for 306,000,000 JV Shares for HK$30,600,000 (51% of JV Company), while Fullshare subscribed for 294,000,000 JV Shares for HK$29,400,000 (49%). The company also provided a Shareholder's Loan of not less than HK$69,400,000 to the JV Company. Fullshare Holdings is a substantial shareholder of the company. Ms. Tian Shanshan, a non-executive director, serves as president assistant of Fullshare Holdings.

Scale indicators10 records

Recent moves7 records

Expansion highlights6 records

HIN Sang Group competitors and assessment

Company assessment

Broad incumbents

  • BYHEALTH Co., Ltd. (300146.SZ): China's largest nutritional supplement manufacturer offering vitamins and supplements including children's health products. Comparable in product category (vitamins, supplements) with broadly overlapping target demographics.
  • China Traditional Chinese Medicine Holdings Limited (570.HK): Large-scale Chinese medicine manufacturer controlled by Sinopharm Group, covering the full TCM value chain from cultivation to retail. Comparable as a regulated Chinese medicine player with manufacturing and distribution; broader in scale than Hin Sang.
  • Infinitus International Company Limited: China-based direct-selling and consumer health products company owned by LKK Health Products Group, focused on Chinese herbal health supplements and personal care. Comparable in TCM-based health products and own-brand distribution model.

Direct peers

  • Purapharm Corporation Limited (formerly listed 8158.HK): Hong Kong-headquartered traditional Chinese medicine company with branded TCM products and Chinese medicine granules. Comparable product portfolio (proprietary Chinese medicine granules) and HK distribution focus.
  • Vita Green Pharmaceutical (Holdings) Limited: Hong Kong-based health supplement and Chinese medicine manufacturer with own brands focused on adult and child health products. Highly comparable as a HK-domiciled CPG health supplements brand using Chinese medicine heritage.
  • Green Cross Healthcare Group Limited: Hong Kong-based health and personal care retailer/distributor operating pharmacy chains and health product distribution. Closely comparable to Hin Sang's pharmacy-led distribution of healthcare products and Chinese medicines across Hong Kong.
  • Beijing Tong Ren Tang Chinese Medicine Co. Ltd. (1666.HK): Hong Kong-listed Chinese medicine company with retail chain distribution and proprietary Chinese medicine products. Comparable in product category (proprietary Chinese medicine) and pharmacy-led retail distribution model.

Emerging players

  • Swisse Wellness Pty Ltd (H&H Group, 1112.HK): Premium Australian vitamins and supplements brand owned by H&H Group (Biostime), heavily distributed in China and Asia through cross-border and pharmacy channels. Comparable as a vitamins/supplements brand competing for the same Chinese consumer.
  • Blackmores Limited (BKL.AX): Asia-Pacific premium vitamins and supplements brand expanding into China and Southeast Asia. Comparable as a brand-led vitamins/supplements specialist with growing Asia presence; competes in the same end-markets as Hin Sang.

Regional players

  • Hengan International Group Company Limited (1044.HK): Hong Kong-listed consumer products company specializing in personal care (tissue, sanitary, skin care) and sold through similar retail pharmacy channels in Greater China. Comparable in personal care product line and Mandarin-speaking market distribution.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

HIN Sang Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

HIN Sang Group leadership team

Management profile

Number of profiles

Profiles7 records

HIN Sang Group subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

HIN Sang Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

HIN Sang Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HIN Sang Group

What does HIN Sang Group do?

Hin Sang Group manufactures and sells children's healthcare products (infant vitamins, nutritional supplements, and adult health products) under the flagship Hin Sang brand, personal care and skincare products under the Beautymate brand, and proprietary Chinese medicines (including the Febrifuge Granules). In addition, the group provides OEM and ODM manufacturing services for external brand owners producing beverages, convenience foods, and confectionery products that meet GMP requirements, operated from its Hin Sang Health Medical Industrial Park in Yunfu City, Guangdong Province.

Is HIN Sang Group a public or private company?

HIN Sang Group is a public company. It is classified as public and is currently operating.

When was HIN Sang Group founded?

HIN Sang Group was founded in 1996. It employs 101 to 250 people.

Where is HIN Sang Group based?

HIN Sang Group is headquartered in Kowloon City, Hong Kong SAR China, in the Asia region.

How does HIN Sang Group make money?

Three revenue lines are on record. Own Brand Product Sales are the primary driver. The others are OEM/ODM Manufacturing Services and property Disposal.

Who are HIN Sang Group's main competitors?

Broad incumbents on record are BYHEALTH Co., Ltd. (300146.SZ), China Traditional Chinese Medicine Holdings Limited (570.HK) and Infinitus International Company Limited. Direct peers are Purapharm Corporation Limited (formerly listed 8158.HK), Vita Green Pharmaceutical (Holdings) Limited, Green Cross Healthcare Group Limited and Beijing Tong Ren Tang Chinese Medicine Co. Ltd. (1666.HK). Emerging players are Swisse Wellness Pty Ltd (H&H Group, 1112.HK) and Blackmores Limited (BKL.AX). Hengan International Group Company Limited (1044.HK) is listed as a regional player.

Does HIN Sang Group have an API?

No public API is recorded for HIN Sang Group.

What industry is HIN Sang Group in?

HIN Sang Group's product category is Children's Healthcare and Nutritional Supplements. Its primary akta.pro industry code is CRADAGAJ, Children’s Vitamins & Supplements, with a secondary code of CRADAMAD, Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges). Its NAICS code is 456 and its SIC code is 2844.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales